Blood Lancets Market by Type, and End User,: Global Opportunity Analysis and Industry Forecast, 2019–2026

Blood Lancets Market by Type, and End User,: Global Opportunity Analysis and Industry Forecast, 2019–2026

  • March 2020 •
  • 165 pages •
  • Report ID: 5897552 •
  • Format: PDF
Blood Lancets Market by Type (Standard, Safety Blood Lancets and Vacuum Blood Lancets), and End User (Hospitals & Clinics, Blood Banks, Homecare and Others),: Global Opportunity Analysis and Industry Forecast, 2019–2026

The global blood lancets market was valued at $901.30 million in 2018 and is expected to reach $1,849.30 million by 2026, registering a CAGR of 9.4% from 2019 to 2026.
Blood lancet is a disposable or single use medical device primarily used for capillary blood sampling. These devices make small punctures in the skin to obtain blood samples that is further used for diagnosis of several diseases such as diabetes hyperlipidemia, blood cholesterol and dyslipidemia. These lancets are widely used by diabetic patients. Patients can easily use these devices at their homes and monitor their blood glucose level.

The major factors driving the growth of the global blood lancets market include significant increase in prevalence of chronic diseases such as diabetes, hyperlipidemia, and dyslipidemia, and rise in inclination toward home care diagnostics, are the major factors driving the blood lancets market growth. In addition, surge in use of disposable blood lancets for painless diagnosis of blood sugar level, hemoglobin, fat level, and other essential blood components, propels the market growth. Disposable lancet prevents the risk of blood transfusion and infection transmission, thereby contributing to the market growth. However, low awareness regarding homecare lancet in developing countries is anticipated to hamper the market growth. Moreover, promising regulatory scenario positively impacts the lancet market growth, thereby, creating lucrative opportunities in the near future.

The market is segmented on the basis of type, end-user, and region. By type, it is segmented into standard, safety blood lancets, and vacuum blood lancets. Based on end user, it is classified into hospitals & clinics, blood banks, homecare and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Type
• Standard
• Safety Blood Lancets
• Vacuum Blood Lancets

By End-User
• Hospitals &Clinics
• Blood Banks
• Homecare
• Others

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Becton, Dickinson & Company
• Improve Medical
• Terumo Corporation
• Sarstedt AG & Co.
• F.L. Medical SRL
• Medtronic plc
• Haemonetics Corporation
• Shangdong Lianfa Medical
• Nipro Medical Corporation
• Abbott Laboratories